FIBROMYALGIA_FARM Flashcards

1
Q

MOA duloxetine

A

SSNRIs antidepressants, no action on receptors/dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

duloxetine has more specificity in blocking what receptors?

A

Ser>NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Duloxetine is metabolized by what CYP enzyme?

A

CYP2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the must know BBW for duloxetine?

A

suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Both duloxetine & milnacipran are eliminated by what mechanism?

A

urinary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA pregabalin

A

works by inhibiting presynaptic alpha-2-delta subunits of L-type Ca2+ channels

  • as a result they inhibit excitatory transmission by glutamate
  • seems to alleviate neuropathic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pregabalin is a schedule ___________ drug

A

V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is pregabalin eliminated?

A

renal elimination unchange (adjust dose in renal failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the notable cautions of pregabalin?

A

rebound w/ drug withdrawal (may cause depend.)
Additive sedation
Monitor pts for depression, suicidal thoughts
In elderly: dizziness sedation, blurred vision, xerostomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which side effects should you be looking for in the elderly taking pregabalin?

A

dizziness
sedation
blurred vision
xerostomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the monitoring parameters for pregabalin?

A

serum creatinine (makes sense because it is eliminated by the kidneys)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cyclobenzaprine MOA

A

central action; possibly at the level of the brain stem (related to amitriptyline)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the FDA indications for cyclobenzaprine?

A

muscle spasm

FM (off label use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is cyclobenzaprine eliminated?

A

enterohepatic recirculation & extensive hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cyclobenzaprine has reduced clearance in the __________ population and in pts w/ _____________ dysfunction

A

elderly, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Amitriptyline and cyclobenzaprine both have significant _________________ action

A

anticholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe the anticholinergic effects of cyclobenzaprine

A
drowsiness
xerostomia
dizziness
fatigue
N/V/C
blurred vision
18
Q

which pts taking cylclobenzaprine are at risk for confusion & cardiac effects & may lead to falling?

19
Q

what are some of the cautions for cylcobenzaprine?

A
additive CNS depression (depressants & EtOH)
additive anticholinergics (GI problems)
20
Q

what is the most significant GI problem with pts taking cyclobenzaprine?

A

GI–>paralytic ileus

21
Q

TCAs have been reported to have what CV adverse effect?

A

QT prolongation (caution w/ antiarrhythmics)

22
Q

Tizanidine MOA

A

agonist at pre-synaptic alpha-2 receptor–>decreased activation of polynaptic spinal cord motor neurons w/ concomitant reduction in muscle tone but NOT MUSCLE STRENGTH

23
Q

which drug reduces muscle tone but not muscle strength?

A

tizanidine

24
Q

how is tizanidine metbolized & excreted?

A

extensive 1st pass metab., short t1/2 w/ extensive renal excretion of long lasting metabolites

25
Q

how would you treat pts w/ tizanidine so as to avoid excessive drug toxicity in elderly and renal pts?

A

dose should be titrated up to effect

26
Q

what are the monitoring parameters of tizanidine?

A

LFTs (hepatocellular toxicity is reported)

-remember extensive 1st pass metab. in liver

27
Q

what are the adverse effects of tizanidine?

A

hepatotoxicity
tapered cessation to avoid rebound hypertonicity
additive CNS depression
additive hypotension
common side effects related to MOA of drug: asthenia, xerostomia, dizziness, sedation, hypotension

28
Q

Baclofen MOA

A

acts as GABAb agonist at multiple levels in spinal cord, producing either inhibitor signals or hyperpolarizing & and so reducing the excitatory (aspartate & glutamate) polysynaptic pathways

  • pain relief in spinal cord comes from inhib. of substance P action
  • sedation at high doses
29
Q

what are the FDA indications for baclofen?

A

multiple sclerosis
muscle spasm
spasticity
spinal cord trauma

30
Q

how is baclofen eliminated?

A

extensive renal elimination

31
Q

what could happen if you give baclofen in pts with renal failure?

A
drug accumulation can lead to:
encephalopathy
abdominal pain
seizures
respiratory depression
32
Q

what could happen if a pt suddenly stops taking baclofen?

A

BBW of rebound neural activity:

  • seizures
  • confusion
  • hallucinations
  • psychiatric disturbances (esp. in pts w/ previous CNS conditions)
  • increased spastcity (maybe–>rhabdomylolysis, MODS, death)
33
Q

dose adjustment of antidiabetic agents may be necessary for which drug that treats spasticity?

A

baclofen (can cause increased BG)

34
Q

what do you have to remember about taking pts off of baclofen?

A

tapered dosing over 2 wks

35
Q

Dantrolene MOA

A

decreases muscle contraction by directly interfering (ryanodine receptor) w/ Ca2+ release from the SR w/i skeletal muscle cells
-effectively uncouples the excitation-contraction process

36
Q

what are the FDA indications for dantrolene?

A

malignant hyperthermia
multiple sclerosis
neuroleptic malignant syndrome
spasticity

37
Q

why does dantroline have a delay in immediate administration?

A

it has to be reconstituted

38
Q

how is dantrolene metabolized & eliminated?

A

hepatically metab. renally eliminated

39
Q

what are the monitoring parameters for dantrolene?

40
Q

IV dantrolene combined w/ CCB in treatment of malignant hyperthermia may produce what?

A

Vfib & CV Collapse

41
Q

what are some common adverse effects of dantrolene?

A

muscle weakness–>drooling, dysarthria, enuresis, myalgias & backache